We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ALSEA:BMVAlsea, S.A.B. de C.V. Analysis

Data as of 2026-06-21 - not real-time

MX$46.86

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Alsea trades at MXN 46.86, sitting below its 20‑day (49.91), 50‑day (51.49) and 200‑day (54.05) moving averages, signaling a short‑term bearish bias. The RSI of 35 and a bearish MACD histogram reinforce downside pressure, while the price hovers just above the identified support at MXN 46.34. Despite the technical weakness, the company boasts a solid dividend yield of 2.13% with a modest payout ratio (~21%), strong operating cash flow (MXN 16.7 bn) and an attractive forward PE of 10.35, suggesting earnings growth ahead. However, the balance sheet is heavily leveraged, with a debt‑to‑equity ratio of 574% and net debt far exceeding cash reserves, raising concerns about financial flexibility. The DCF‑derived fair value of MXN 44.57 places the current price modestly above intrinsic estimates, hinting at slight overvaluation, yet analyst consensus targets around MXN 67 imply a sizable upside (~43%). The market sentiment is exuberant, reflected by a Fear & Greed Index of 91.46 (Extreme Greed), which may be inflating price expectations. Overall, Alsea presents a mixed picture: technical downside, strong cash generation, high leverage, and a dividend that remains sustainable under current cash flows.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support with bearish momentum
  • Strong dividend yield and low payout ratio
  • Elevated leverage increasing financial risk

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward PE of 10.35 indicating earnings upside
  • Analyst target price around MXN 67 suggesting 40% upside
  • Robust operating cash flow supporting dividend and debt service

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Diversified brand portfolio across Latin America and Europe
  • Sustainable dividend backed by cash flow generation
  • Potential to deleverage over time improving balance‑sheet strength

Key Metrics & Analysis

Financial Health

Revenue Growth0.30%
Profit Margin2.45%
P/E Ratio18.4
ROE25.39%
ROA6.56%
Debt/Equity574.80
P/B Ratio4.2
Op. Cash FlowMX$16.7B
Free Cash FlowMX$6.1B

Technical Analysis

TrendBearish
RSI35.0
SupportMX$46.34
ResistanceMX$53.77
MA 20MX$49.91
MA 50MX$51.49
MA 200MX$54.05
MACDBearish
VolumeIncreasing
Fear & Greed Index91.46

Valuation

Fair ValueMX$44.57
Target PriceMX$67.25
Upside/Downside43.50%
GradeFair
TypeBlend
Dividend Yield2.13%

Risk Assessment

Beta0.38
Volatility29.47%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.